Sidley Advises Vim in US$60 Million Series B Funding Round
May 5, 2021
Related Professionals
Stay Up To Date
Sidley represented Vim, a San Francisco and Tel Aviv-based technology provider of online healthcare services in the U.S., in the completion of a US$60 million Series B funding round led by Walgreens, Anthem, and Optum Ventures, with participation from Great Point Ventures, Sequoia Capital, Frist Cressey Ventures, and Premera Blue Cross.
Idan Netser (Emerging Companies, Venture Capital and Tax) and Alina Azizian (Emerging Companies and Venture Capital) led the Sidley team, which included Justin Stone (Emerging Companies and Venture Capital), and Nick DeAngelis (M&A).
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.
You have successfully set your edition to United States. Would you like to make this selection your default edition?
*Selecting a default edition will set a cookie.
This website uses cookies. Analytical cookies help us improve our website by providing insight on how visitors interact with our site, and necessary cookies which the website needs to function properly.
Necessary Cookies
The website cannot function properly without these necessary cookies, and they can only be disabled by changing your browser preferences. To learn more about these cookies, how we use them on our website, and how to revise your cookie settings, please view our cookie policy.